Atlas Pearls Ltd (ATP) ORDINARY FULLY PAID |
Consumer Discretionary |
$61 |
Half-Year Financial Report & Dividend Announcement - H1 FY25
|
27 Feb 2025 6:29PM |
$0.145 |
$0.140 |
fallen by
3.45%
|
|
ATP - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from contracts up 29% to $19.1M from H2 FY24
- Net profit after tax of $12.7M for H1 FY25
- Interim and special dividend declared: 1.00 cents/share (unfranked)
- Normalised EBITDA up 21% to $7.1M from H2 FY24
- Average selling price for pearls was $65, down from $103 last year
- Pearls sold increased by 28% to 284,071 in H1 FY25
- Diverse sales channels strengthened, with private sales increasing significantly
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Estrella Resources Limited (ESR) ORDINARY FULLY PAID |
Materials |
$76 |
Cleansing notice under s708A
|
27 Feb 2025 6:28PM |
$0.027 |
$0.037 |
risen by
37.04%
|
|
Canadian Phosphate Limited (CP8) ORDINARY FULLY PAID |
Materials |
$10 |
Application for quotation of securities - CP8
|
27 Feb 2025 6:28PM |
n/a |
$0.031 |
n/a
|
|
Estrella Resources Limited (ESR) ORDINARY FULLY PAID |
Materials |
$76 |
Application for quotation of securities - ESR
|
27 Feb 2025 6:27PM |
$0.027 |
$0.037 |
risen by
37.04%
|
|
Perenti Limited (PRN) ORDINARY FULLY PAID |
Materials |
$1,473 |
Update - Notification of buy-back - PRN
|
27 Feb 2025 6:27PM |
$1.250 |
$1.585 |
risen by
26.80%
|
|
Queste Communications Limited (QUE) ORDINARY FULLY PAID |
Financials |
$1 |
Half Year Report - 31 December 2024
|
27 Feb 2025 6:27PM |
$0.044 |
$0.040 |
fallen by
9.09%
|
|
QUE - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenues increased to $110,541, a rise of 360%.
- Consolidated profit after tax increased to $1,182,752, marking an 833% rise.
- The report identifies an income tax benefit contributing to improved financial performance.
- The company continues to manage accumulated losses despite operational successes.
- Investments primarily involve Orion Equities Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Cobalt Blue Holdings Limited (COB) ORDINARY FULLY PAID |
Materials |
$25 |
R&D advance loan facility and CMAI instalment receipt
|
27 Feb 2025 6:25PM |
$0.054 |
$0.056 |
risen by
3.70%
|
|
COB - Price-sensitive ASX Announcement
Full Release
Key Points
- Cobalt Blue Holdings Limited secured $700,000 loan from Radium Capital.
- Loan is secured against the R&D Tax Incentive refund for FY25.
- Funding will assist in finalizing the production flowsheet for the Kwinana Refinery Project.
- Received a CMAI grant installment of $500,000.
- Total grant funds received to date amount to $14.0 million.
- Cash and equivalents on hand total $2.94 million as of February 27, 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Cambium Bio Limited (CMB) ORDINARY FULLY PAID |
Health Care |
$3 |
Half Year Report and Accounts
|
27 Feb 2025 6:25PM |
$0.400 |
$0.190 |
fallen by
52.50%
|
|
CMB - Price-sensitive ASX Announcement
Full Release
Key Points
- Cambium Bio Limited reported a loss of $1.73 million for the half-year ending December 31, 2024.
- The company's revenue for the period was $278k, mainly from royalty payments.
- R&D expenses increased significantly to $1.58 million compared to $30k in the previous year.
- Cambium Bio raised $3 million in capital, strengthening its financial position.
- Elate Ocular® received FDA Fast Track designation, facilitating its journey towards Phase 3 clinical trials.
- Cash reserves at the end of the reporting period were $548k, with additional funds expected from pending approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Atlas Pearls Ltd (ATP) ORDINARY FULLY PAID |
Consumer Discretionary |
$61 |
Appendix 4D and Half-Year Report
|
27 Feb 2025 6:23PM |
$0.145 |
$0.140 |
fallen by
3.45%
|
|
ATP - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue decreased by 29% to $19,133,938.
- Net profit after tax fell by 38% to $12,724,611.
- Average selling price per pearl decreased from $103 to $65.
- The company harvested 250,000 pearls during the period.
- Interim dividend of 0.61 cents per share declared.
- Special dividend of 0.39 cents per share declared.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Orion Equities Limited (OEQ) ORDINARY FULLY PAID |
Financials |
$2 |
Half Year Report - 31 December 2024
|
27 Feb 2025 6:19PM |
$0.130 |
$0.145 |
risen by
11.54%
|
|
OEQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenues increased to $123,584 from $33,043.
- Net loss before tax was $170,292.
- Recognized an income tax benefit of $1.41 million.
- Profit after tax amounted to $1,241,234.
- No dividends were declared for the financial half year.
- Net tangible asset backing per share reported at $0.415.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Brightstar Resources Limited (BTR) ORDINARY FULLY PAID |
Materials |
$314 |
Change of Director's Interest Notice
|
27 Feb 2025 6:13PM |
$0.020 |
$0.665 |
risen by
3,225%
|
|
Pengana Capital Group Limited (PCG) ORDINARY FULLY PAID |
Financials |
$80 |
Shareholder Presentation Results 31 December 2024
|
27 Feb 2025 6:12PM |
$0.900 |
$0.810 |
fallen by
10%
|
|
PCG - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong profitability in H1 FY 2025.
- Interim dividend increased to 2 cents per share, up 100% from the prior year.
- Underlying profit before tax rose to $8.173 million.
- Performance fees returned significantly following successful fund performances.
- Funds under management growth driven by higher margin products.
- Successful launch of Global Private Credit funds contributing to revenue.
- Reported earnings per share on underlying profit increased to 5.28 cps.
- Statutory profit after tax attributable to shareholders improved to $3.498 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Entyr Limited (ETR) ORDINARY FULLY PAID |
Industrials |
$14 |
Further Extension of DOCA end date
|
27 Feb 2025 6:11PM |
$0.007 |
$0.007 |
fallen by
0%
|
|
Zoom2u Technologies Limited (Z2U) ORDINARY FULLY PAID |
Information Technology |
- |
Half Yearly Report and Accounts
|
27 Feb 2025 6:11PM |
$0.069 |
$0.051 |
fallen by
26.09%
|
|
Z2U - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased to $3,192,607, a 10% rise from last period.
- Loss after tax reduced by 50% to $846,058.
- Locate2u revenue grew by 10% to $1,324,489.
- Zoom2u courier platform revenue declined by 3% to $1,531,575.
- Operating costs decreased, contributing to an EBITDA of $45,027.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Australian Gold and Copper Ltd (AGC) ORDINARY FULLY PAID |
Materials |
$40 |
Change of Director's Interest Notice
|
27 Feb 2025 6:09PM |
$0.165 |
$0.155 |
fallen by
6.06%
|
|
Bio-Gene Technology Ltd (BGT) ORDINARY FULLY PAID |
Materials |
$6 |
Appendix 4D and Half-Year Accounts 31 December 2024
|
27 Feb 2025 6:09PM |
$0.033 |
$0.023 |
fallen by
30.30%
|
|
BGT - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss for the half-year of $1,464,772, down from the previous year's loss.
- Collaboration with Envu to develop Flavocide for mosquito management.
- Completion of pilot-scale production of Flavocide by Rallis India.
- Thirteenth Qcide harvest completed.
- Secured two grants from the U.S. Department of Defense totaling $3 million.
- Significant strengthening of intellectual property portfolio with new patents.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Pengana Capital Group Limited (PCG) ORDINARY FULLY PAID |
Financials |
$80 |
Dividend/Distribution - PCG
|
27 Feb 2025 6:07PM |
$0.900 |
$0.810 |
fallen by
10%
|
|
Pengana Capital Group Limited (PCG) ORDINARY FULLY PAID |
Financials |
$80 |
PCG Appendix 4D and Interim Report 31 December 2024
|
27 Feb 2025 6:06PM |
$0.900 |
$0.810 |
fallen by
10%
|
|
PCG - Price-sensitive ASX Announcement
Full Release
Key Points
- Profit for the half-year is $3,498,000, up from a loss of $873,000.
- Revenue from ordinary activities increased by 92% to $34,906,000.
- Declared an interim dividend of 2.0 cents per share.
- Total assets amounted to $127,780,000.
- Total equity reached $86,182,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
St Barbara Limited (SBM) ORDINARY FULLY PAID |
Materials |
$341 |
Updated Appendix 3Y Mark Hine
|
27 Feb 2025 6:04PM |
$0.230 |
$0.315 |
risen by
36.96%
|
|
Peregrine Gold Ltd (PGD) ORDINARY FULLY PAID |
Materials |
$12 |
Appointment of Joint Company Secretary
|
27 Feb 2025 6:04PM |
$0.115 |
$0.140 |
risen by
21.74%
|
|
ARC Funds Limited (ARC) ORDINARY FULLY PAID |
Financials |
$5 |
Term Deposit Shop Exercise of Call Option
|
27 Feb 2025 6:03PM |
$0.120 |
$0.096 |
fallen by
20%
|
|
Zoom2u Technologies Limited (Z2U) ORDINARY FULLY PAID |
Information Technology |
- |
Company Secretary Appointment/Resignation
|
27 Feb 2025 6:01PM |
$0.069 |
$0.051 |
fallen by
26.09%
|
|
Alliance Aviation Services Limited (AQZ) ORDINARY FULLY PAID |
Industrials |
$394 |
Change of Director's Interest Notice - Stanton
|
27 Feb 2025 5:59PM |
$2.730 |
$2.450 |
fallen by
10.26%
|
|
Mighty Kingdom Limited (MKL) ORDINARY FULLY PAID |
Communication Services |
$7 |
Half Yearly Report and Accounts
|
27 Feb 2025 5:59PM |
$0.007 |
$0.014 |
risen by
100%
|
|
MKL - Price-sensitive ASX Announcement
Full Release
Key Points
- Total comprehensive loss of $1.7 million for H1 FY25.
- Game revenue decreased by 32%, totaling $2.5 million.
- Operating expenses reduced by 30% compared to H2 FY24.
- Management changes included new appointments for Chair and Interim CEO.
- Partnerships with Google and Spin Master were strengthened.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Seafarms Group Limited (SFG) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
SFG Appendix 4D - 2025 Half-Year Report
|
27 Feb 2025 5:55PM |
$0.002 |
$0.002 |
fallen by
25%
|
|
SFG - Price-sensitive ASX Announcement
Full Release
Key Points
- Seafarms Group continues to invest in the development of Project Sea Dragon.
- The Group’s half-year loss of $6.7 million reflects the continued investment in Project Sea Dragon.
- Total production was 480 tonnes compared to 697 tonnes in the prior period.
- Court-appointed liquidators are seeking approval to become administrators.
- 75 tonnes of raw tiger prawns were exported in HY25, reflecting ongoing investment.
- Half-year sales revenue included $1.2 million from the sale of post-larvae.
- Sale of Farm 1 and Farm 2 became unconditional on August 20, 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.